Clinical AI Company HealthReveal Expands Executive Team to Fuel Growth

New York, NY – October 29, 2019 – HealthReveal, a clinical AI company, today announced the expansion of its executive team with the addition of Mina Egan as chief commercial officer, and Ed Liebowitz as chief product officer. Egan will drive commercial sales efforts aimed at new health systems, plans and employers. Liebowitz will direct the product strategy and roadmap as HealthReveal adds new AI and machine learning capabilities to its platform. The company is actively monitoring 200,000 individual patients with chronic disease to ensure that each patient receives optimal and personalized care informed by the latest medical guidelines on an ongoing basis. 

“HealthReveal’s mission is to ensure all people living with chronic disease receive optimal, personalized care. We get there by using technology – and evidence – to level the playing field,” said founder and CEO Lonny Reisman. “Mina and Ed bring a tremendous level of expertise in the area of clinical innovation, platform design and application for patients with chronic disease, and their leadership will help us forge new partnerships with some of the largest healthcare stakeholders in the country.”

Egan joins from Optum, where she served as a vice president with the Clinovations group. In this role, she was responsible for business development and oversaw client engagements with leading hospitals and health systems with a focus on health IT optimization. Prior to Optum, Egan drove the development of McKesson’s population health services strategy as director of strategy and business development at McKesson Health IT. Egan’s prior experience also includes overseeing the design, build, and implementation of a provider-owned health plan at Evolent Health. 

“Health systems, plans and employers all want to optimize and personalize patient care delivery and outcomes,” said Egan. “Unlike many point solutions on the market, HealthReveal’s clinical AI platform delivers actionable, patient-specific treatment recommendations to serve all three channels on their mission.”

Liebowitz joins HealthReveal from Becton Dickinson, where as Global Director of the Digital Diabetes Portfolio, he led all product development and go to market planning and execution for the group. Prior to BD, Liebowitz served as VP of Digital Products at Everyday Health Group, where he oversaw the product roadmap, development, strategy, execution and campaign operations for the Payer / Provider digital product portfolio. 

“I’m thrilled to be joining HealthReveal at such a pivotal time in the AI adoption curve across the healthcare ecosystem,” said Liebowitz. “The company’s clinical AI platform was built with medical evidence and the guidelines at its core, and approaches clinical AI from a place of transparency – something we don’t see much of among AI companies.” 

HealthReveal co-founder and digital health industry veteran Lori Evans Berstein will take on the role of President in addition to her current responsibilities as Chief Operating Officer.  Evans Bernstein and founder and CEO Lonny Reisman started HealthReveal in 2015.

HealthReveal helps payors, providers and self-insured employers improve care for their patients and members who suffer from chronic disease. The company’s clinical artificial intelligence (AI) solution continually applies the latest medical guidelines to individual patient health data. When HealthReveal detects an opportunity for an optimal course of treatment, it proactively issues a “Reveal” to clinicians with a personalized and precise care recommendation. Our solution continually monitors as new patient data emerges and issues additional Reveals to clinicians, care teams and patients over time.

About HealthReveal

HealthReveal is a clinical artificial intelligent (AI) company that helps payors, providers and self-insured employers ensure that patients receive optimal, personalized care. The company’s solution continually applies the latest medical guidelines to individual patient health data. The results are proactive, patient-specific, precise diagnostic and treatment recommendations – Reveals – for clinicians, care teams and patients. Learn more at